Erratum to: Comparative efficacy and safety of caffeine and aminophylline for apnea of prematurity in preterm (≤34 weeks) neonates: A randomized controlled trial (Indian Pediatr., (2017), 54, (279-83), 10.1007/s13312-017-1088-0)

M. Shivakumar; P. Jayashree; Muhammad Najih; Leslie Edward Simon Lewis; Y. Ramesh Bhat; Asha Kamath; Shashikala

doi:10.1007/s13312-017-1160-9

Erratum to: Comparative efficacy and safety of caffeine and aminophylline for apnea of prematurity in preterm (≤34 weeks) neonates: A randomized controlled trial (Indian Pediatr., (2017), 54, (279-83), 10.1007/s13312-017-1088-0)

M. Shivakumar, P. Jayashree, Muhammad Najih, Leslie Edward Simon Lewis, Y. Ramesh Bhat, Asha Kamath, Shashikala

Research output: Contribution to journal › Comment/debate

Abstract

In Table II, P value in first row (against ‘continuing apnea’ at 1–3 d of therapy) should be 0.05 in place of 0.03; and in second row (against ‘continuing apnea’ at 4–7 d of therapy), P value should be 0.03 in place of 0.05. In Fig. 1, the number in the frame “Neonates completed treatment and follow-up” in the Caffeine group should be read as 77 in place of 79; and in the Aminophylline group, it should be 79 in place of 77.

Original language	English
Number of pages	1
Journal	Indian Pediatrics
Volume	54
Issue number	10
DOIs	https://doi.org/10.1007/s13312-017-1160-9
Publication status	Published - 01-10-2017

All Science Journal Classification (ASJC) codes

Pediatrics, Perinatology, and Child Health

Access to Document

10.1007/s13312-017-1160-9

Fingerprint Dive into the research topics of 'Erratum to: Comparative efficacy and safety of caffeine and aminophylline for apnea of prematurity in preterm (≤34 weeks) neonates: A randomized controlled trial (Indian Pediatr., (2017), 54, (279-83), 10.1007/s13312-017-1088-0)'. Together they form a unique fingerprint.

Cite this

Shivakumar, M., Jayashree, P., Najih, M., Lewis, L. E. S., Ramesh Bhat, Y., Kamath, A., & Shashikala (2017). Erratum to: Comparative efficacy and safety of caffeine and aminophylline for apnea of prematurity in preterm (≤34 weeks) neonates: A randomized controlled trial (Indian Pediatr., (2017), 54, (279-83), 10.1007/s13312-017-1088-0). Indian Pediatrics, 54(10). https://doi.org/10.1007/s13312-017-1160-9

Shivakumar, M. ; Jayashree, P. ; Najih, Muhammad ; Lewis, Leslie Edward Simon ; Ramesh Bhat, Y. ; Kamath, Asha ; Shashikala. / Erratum to : Comparative efficacy and safety of caffeine and aminophylline for apnea of prematurity in preterm (≤34 weeks) neonates: A randomized controlled trial (Indian Pediatr., (2017), 54, (279-83), 10.1007/s13312-017-1088-0). In: Indian Pediatrics. 2017 ; Vol. 54, No. 10.

@article{b9f24f79cdd645a7b98ac1697da445b3,

title = "Erratum to: Comparative efficacy and safety of caffeine and aminophylline for apnea of prematurity in preterm (≤34 weeks) neonates: A randomized controlled trial (Indian Pediatr., (2017), 54, (279-83), 10.1007/s13312-017-1088-0)",

abstract = "In Table II, P value in first row (against {\textquoteleft}continuing apnea{\textquoteright} at 1–3 d of therapy) should be 0.05 in place of 0.03; and in second row (against {\textquoteleft}continuing apnea{\textquoteright} at 4–7 d of therapy), P value should be 0.03 in place of 0.05. In Fig. 1, the number in the frame “Neonates completed treatment and follow-up” in the Caffeine group should be read as 77 in place of 79; and in the Aminophylline group, it should be 79 in place of 77.",

author = "M. Shivakumar and P. Jayashree and Muhammad Najih and Lewis, {Leslie Edward Simon} and {Ramesh Bhat}, Y. and Asha Kamath and Shashikala",

year = "2017",

month = oct,

day = "1",

doi = "10.1007/s13312-017-1160-9",

language = "English",

volume = "54",

journal = "Indian Pediatrics",

issn = "0019-6061",

publisher = "Springer India",

number = "10",

}

Shivakumar, M, Jayashree, P, Najih, M, Lewis, LES , Ramesh Bhat, Y , Kamath, A & Shashikala 2017, 'Erratum to: Comparative efficacy and safety of caffeine and aminophylline for apnea of prematurity in preterm (≤34 weeks) neonates: A randomized controlled trial (Indian Pediatr., (2017), 54, (279-83), 10.1007/s13312-017-1088-0)', Indian Pediatrics, vol. 54, no. 10. https://doi.org/10.1007/s13312-017-1160-9

Erratum to : Comparative efficacy and safety of caffeine and aminophylline for apnea of prematurity in preterm (≤34 weeks) neonates: A randomized controlled trial (Indian Pediatr., (2017), 54, (279-83), 10.1007/s13312-017-1088-0). / Shivakumar, M.; Jayashree, P.; Najih, Muhammad; Lewis, Leslie Edward Simon ; Ramesh Bhat, Y.; Kamath, Asha; Shashikala.

In: Indian Pediatrics, Vol. 54, No. 10, 01.10.2017.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum to

T2 - Comparative efficacy and safety of caffeine and aminophylline for apnea of prematurity in preterm (≤34 weeks) neonates: A randomized controlled trial (Indian Pediatr., (2017), 54, (279-83), 10.1007/s13312-017-1088-0)

AU - Shivakumar, M.

AU - Jayashree, P.

AU - Najih, Muhammad

AU - Lewis, Leslie Edward Simon

AU - Ramesh Bhat, Y.

AU - Kamath, Asha

AU - Shashikala,

PY - 2017/10/1

Y1 - 2017/10/1

N2 - In Table II, P value in first row (against ‘continuing apnea’ at 1–3 d of therapy) should be 0.05 in place of 0.03; and in second row (against ‘continuing apnea’ at 4–7 d of therapy), P value should be 0.03 in place of 0.05. In Fig. 1, the number in the frame “Neonates completed treatment and follow-up” in the Caffeine group should be read as 77 in place of 79; and in the Aminophylline group, it should be 79 in place of 77.

AB - In Table II, P value in first row (against ‘continuing apnea’ at 1–3 d of therapy) should be 0.05 in place of 0.03; and in second row (against ‘continuing apnea’ at 4–7 d of therapy), P value should be 0.03 in place of 0.05. In Fig. 1, the number in the frame “Neonates completed treatment and follow-up” in the Caffeine group should be read as 77 in place of 79; and in the Aminophylline group, it should be 79 in place of 77.

UR - http://www.scopus.com/inward/record.url?scp=85032265300&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032265300&partnerID=8YFLogxK

U2 - 10.1007/s13312-017-1160-9

DO - 10.1007/s13312-017-1160-9

M3 - Comment/debate

AN - SCOPUS:85032265300

VL - 54

JO - Indian Pediatrics

JF - Indian Pediatrics

SN - 0019-6061

IS - 10

ER -

Shivakumar M, Jayashree P, Najih M, Lewis LES , Ramesh Bhat Y , Kamath A et al. Erratum to: Comparative efficacy and safety of caffeine and aminophylline for apnea of prematurity in preterm (≤34 weeks) neonates: A randomized controlled trial (Indian Pediatr., (2017), 54, (279-83), 10.1007/s13312-017-1088-0). Indian Pediatrics. 2017 Oct 1;54(10). https://doi.org/10.1007/s13312-017-1160-9